2-(4-Bromo-2-methylphenyl)-5-methyl-1,3,4-oxadiazole → 2,3'-Dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxylic acid
Reaktionsgleichung
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([CH3:13])=[N:11][N:12]=2)=[C:4]([CH3:14])[CH:3]=1.B([C:18]1[CH:26]=[CH:25][C:21]([C:22]([OH:24])=[O:23])=[CH:20][C:19]=1[CH3:27])(O)O>>[CH3:27][C:19]1[CH:20]=[C:21]([C:22]([OH:24])=[O:23])[CH:25]=[CH:26][C:18]=1[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([CH3:13])=[N:11][N:12]=2)=[C:4]([CH3:14])[CH:3]=1Komponenten
3
Versuchsvorschrift
The title compound was prepared from 2-(4-bromo-2-methylphenyl)-5-methyl-1,3,4-oxadiazole (D35) and 4-borono-3-methylbenzoic acid (D33) using a similar procedure to Description 11 as a white solid (24%).
Quellen und Nachweise
- ORD-Eintrag
- ord-0433ea6ce8fd487b8a4d8f1d28cb7e17
- Quelldatensatz
- uspto-grants-1999_10